Delivery Order SPE2DB24D2205-SPE2DB25FEGNZ
- Not listed
- The Defense Logistics Agency awarded a $1,711.16 delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector units on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector pharmaceutical product with a ceiling value of $2,444.49. This competitively awarded, firm fixed price delivery order is set to be completed by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction within the broader federal medical supply procurement landscape...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.44 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies, with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,372.49 to AmerisourceBergen Drug Corp for the supply of Xyosted 100 mg/0.5 mL auto-injector units. This is a firm fixed price, competitively awarded contract with no set-aside designation, completed on August 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance for this federal procurement. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector pharmaceutical products, valued at $3,572.94 under a firm fixed-price delivery order contract. The award, issued on July 31, 2025, with completion scheduled for August 1, 2025, represents a non-competitive delivery order without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,230.21 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector units on August 6, 2025, with completion targeted for August 7, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement from AmerisourceBergen's existing pharmaceutical supply contract with DLA. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,086.44 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector units. This non-set-aside, competitively awarded delivery order was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a firm fixed price transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector units, valued at $1,384.82 under a firm fixed price contract structure. This delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,429.20 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 11, 2025, issued on September 10, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,388.60 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Xyosted 100 mg/0.5 ml auto-injector (0.5 ml). This competitive award, utilizing firm fixed pricing with no set-aside designation, is scheduled for completion by August 14, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGNZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,814.41 to AmerisourceBergen Drug Corp for Xyosted 50 mg/0.5 mL auto-injector pharmaceutical supplies. The contract is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and was competitively awarded without a set-aside designation. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare systems globally, enabling the company to deliver a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability to fulfill federal medical procurement requirements through competitive awards and serves as a critical vendor for Department of Defense medical supply chain needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/21/25 |